Development of a HIV-1 vaccine using an orally-administered, replication-competent adenovirus serotype 4 vector expressing Env clade C glycoprotein

by Alexander J, Gurwith M, Mendy J, Vang L, Manayani D, Avanzini J, Guenther B, Farness P, Haynes BF, Liao H, Montefiori DC, LaBranche CC, Mayall T
Published 2012-09-01